{
    "Trade/Device Name(s)": [
        "BD Vacutainer\u00ae K2 EDTA Blood Collection Tubes"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K231373",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981013"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GIM",
        "JKA"
    ],
    "Summary Letter Date": "January 4, 2024",
    "Summary Letter Received Date": "January 4, 2024",
    "Submission Date": "December 22, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Human venous blood"
    ],
    "Specimen Container(s)": [
        "BD Vacutainer\u00ae K2 EDTA Blood Collection Tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Evacuated blood collection tube",
        "K2 EDTA anticoagulation"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device",
        "Tube",
        "Container"
    ],
    "Document Summary": "FDA 510(k) summary for BD Vacutainer K2 EDTA Blood Collection Tubes used for venous blood collection and HbA1c testing",
    "Indications for Use Summary": "Intended for trained healthcare professionals to collect, contain, preserve, and transport human venous blood specimens for in vitro diagnostic testing, including Hemoglobin A1c (HbA1c) testing",
    "fda_folder": "Clinical Chemistry"
}